实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (5): 745-748.doi: 10.3969/j.issn.1672-5069.2018.05.023

• 肝癌 • 上一篇    下一篇

丙泊酚对肝部分切除术治疗的原发性肝癌患者外周血淋巴细胞亚群和血清肿瘤相关标志物水平的影响

伍家彬, 谢晓海   

  1. 625000 四川省雅安市人民医院麻醉科(伍家彬); 四川省妇幼保健院麻醉科(谢晓海)
  • 收稿日期:2017-10-25 出版日期:2018-09-10 发布日期:2018-09-27
  • 作者简介:伍家彬,男,39岁,大学本科,副主任医师。主要从事麻醉学研究。E-mail:glk7795@163.com

Effects of propofol on peripheral blood lymphocyte subsets and serum tumor related markers in patients with primary liver cancer receiving partial hepatectomy

Wu Jiabing, Xie Xiaohai.   

  1. Department of Anesthesiology,People’s Hospital,Ya'an 625000,Sichuan Province,China
  • Received:2017-10-25 Online:2018-09-10 Published:2018-09-27

摘要: 目的 探讨丙泊酚对肝部分切除术治疗的原发性肝癌(PLC)患者外周血T淋巴细胞亚群和血清肿瘤相关标志物水平的影响。方法 2010年2月~2014年4月我院收治的PLC患者92例,采用随机数字表法将患者分为丙泊酚组和异氟醚组,每组46例。在行肝叶切除术时,分别采用相应的麻醉方法。使用流式细胞仪检测外周血CD3+、CD4+、CD8+细胞百分比和CD4+/CD8+细胞比值,采用酶联免疫吸附法检测血清E-钙蛋白(EC)、血管内皮生长因子(VEGF)和基质金属蛋白酶(MMP)水平,并观察两组不良反应和生存情况。结果 在麻醉前,两组外周血CD3+、CD4+、CD8+细胞百分比和CD4+/CD8+细胞比值无显著性差异(P>0.05),在术后1d,丙泊酚麻醉组血CD3+和CD4+细胞分别为(56.3±4.8) %和(36.8±5.7) %,显著高于异氟醚组的(52.5±4.5)%和(34.2±4.2)%(P<0.05);在麻醉前,两组血清EC、VEGF和MMP水平无显著性差异(P>0.05),在术后14d,丙泊酚麻醉组血清EC、VEGF和MMP水平分别为(1763.3±112.7) ng/ml、(201.9±36.9) pg/ml和(32.4±4.2)ng/L,显著低于异氟醚组的(2318.4±153.9) ng/ml、(369.9±56.8) pg/ml和(72.5±7.2) ng/L(P<0.05);术后丙泊酚组白细胞下降发生率为47.8%,显著低于异氟醚组的69.6%(P<0.05);随访3年,两组患者生存率无显著性差异(P>0.05)。结论 丙泊酚可有效减轻PLC患者术后免疫抑制状态,减少并发症的发生,可能有助于患者术后的康复。

关键词: 原发性肝癌, 丙泊酚, 麻醉, 外周血淋巴细胞亚群, 血清肿瘤相关标志物

Abstract: Objective To investigate the effectsof propofol on peripheral blood lymphocyte subsets and serum tumor related markers in patients with primary liver cancer(PLC) receiving partial hepatectomy(PH). Methods A total of 92 patients with PLC were recruited in our hospital between February 2010 and April 2014,and were divided into propofol and isoflurane group,with 46 in each when PH was done. The percentages of peripheral blood lymphocyte subsets were detected by FCM,and serum E-cadherin(EC),vascular endothelial growth factor(VEGF) and matrix metalloproteinase(MMP) levels were detected by ELISA. Results The percentages of peripheral blood CD3+,CD4+ and CD8+ cells,and the ratio of CD4+/CD8+ showed no significant differences between the two groups before anesthesia(P>0.05),while 1 day after operation,the percentage of CD3+ and CD4+ cells were (56.3±4.8)% and (36.8±5.7)% in the propofol group,significantly higher than (52.5±4.5)% and (34.2±4.2)% in the isoflurane group (P<0.05);before anesthesia,there was no significant difference as recpect to serum EC,VEGF and MMP levels between the two group(P>0.05),while 14 days after operation,serum levels of these three cytokines were (1763±112.7) ng/ml,(201.9±36.9) pg/ml and(32.4±4.2) ng/L in the propofol group,significantly lower than (2318±153.9) ng/ml,(369.9±56.8) pg/mL and(72.5±7.2) ng/L in the isoflurane group (P<0.05);the incidence rate of leukopenia in the propofol group was significantly lower than that in the isoflurane group(47.8% vs. 69.6%,P<0.05);there were no significant differences between the two groups as respect to the postoperative 3-year survival rates(P>0.05). Conclusion Propofol can effectively relieve the postoperative immunosuppression in patients with PLC,which might inhibit tumor cell metastasis and improve the recovery.

Key words: Hepatoma, Aneasthesia, Propofol, Peripheral blood lymphocyte subsets, Serum tumor related markers